Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
PRESS RELEASES
The Buxton Helmsley Group To Call Meeting Of Mallinckrodt Shareholders To Realign Board And Management With Shareholder Interests, Renegotiate Restructuring Plan
By PR Newswire
Jan 15, 2021 3:18 PM EST
PRESS RELEASES
Mallinckrodt Announces Real World Data On Hepatorenal Syndrome (HRS) And Acute Kidney Injury (AKI) In Patients With Liver Disease At The Liver Meeting Digital Experience
By PR Newswire
Nov 16, 2020 6:45 AM EST
PRESS RELEASES
Mallinckrodt Announces Data From A Multicenter Post Hoc Analysis Of Terlipressin In Patients With Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) At The Liver Meeting Digital Experience
By PR Newswire
Nov 16, 2020 6:30 AM EST
PRESS RELEASES
Mallinckrodt Initiates Retrospective Study Of The Use Of Inhaled Nitric Oxide In COVID-19 Patients
By PR Newswire
Nov 10, 2020 6:47 AM EST
PRESS RELEASES
Mallinckrodt Announces Data At Kidney Week 2020 Reimagined That Showed A Potential For Reduced Need For Renal Replacement (RRT) Therapy For Patients With Hepatorenal Syndrome Type 1 (HRS-1) Treated With Terlipressin
By PR Newswire
Oct 29, 2020 6:35 AM EDT
